wx-081
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Feb 13, 2019 (NCT06117514)
Timeline
Indications
Mechanism of action
- Mycobacterium tuberculosisINHIBITOR
Mycobacterium tuberculosis inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
COc1ncc(-c2ccc(Cl)cc2)cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12- Mol. weight
- 537.1 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314931 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06701136 | Phase 1 | Dec 12, 2024 | Shanghai Jiatan Pharmatech Co., Ltd |
| NCT06701110 | Phase 1 | Sep 4, 2024 | Shanghai Jiatan Pharmatech Co., Ltd |
| NCT05824871 | Phase 3 | Sep 2, 2022 | Capital Medical University, Shanghai Jiatan Pharmatech Co., Ltd |
| NCT04608955 | Phase 2 | Nov 1, 2020 | Shanghai Jiatan Pharmatech Co., Ltd |
| NCT06117514 | Phase 1 | Feb 13, 2019 | Shanghai Jiatan Pharmatech Co., Ltd, Shanghai Xuhui District Central Hospital |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Jiatan Pharmatech Co., Ltd | Government | 5 | 5 | 3 | 2019 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Shanghai Xuhui District Central Hospital | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1